Back

Predictors, feasibility and outcomes of coronary interventions up to 3 years after TAVI with a balloon-expandable valve. Results from a large European multicenter registry.

2 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Structural percutaneous intervention Aortic Valve Stenosis ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Giuseppe Tarantini

University of Padua, Padova (Italy)

8 More presentations in this session

Presentation thumbnail
Doctor K. Waki (Kurashiki, JP)
Abstract Slides
Presentation thumbnail
Doctor M. Potratz (Bad Oeynhausen, DE)
Abstract Slides
Presentation thumbnail
Doctor L. Kalinczuk (Warsaw, PL)
Abstract
Presentation thumbnail
Professor V. Veulemans (Duesseldorf, DE)
Abstract
Presentation thumbnail
Doctor T. Luque Diaz (Madrid, ES)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Structural percutaneous intervention

The Event

Event poster

ESC Congress 2019

2 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Clinical outcomes of patients undergoing percutaneous coronary intervention and transcatheter aortic valve implantation versus coronary artery bypass grafting and surgical aortic valve replacement
thumbnail
Congress Presentation
Impact of obstructive coronary artery disease on clinical and health status in patients undergoing transcatheter aortic valve implantation
thumbnail
Congress Presentation
Coronary angiography and intervention after transcatheter aortic valve implantation (TAVI): the nationwide SWEDEHEART registry

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources